Candice McCoy

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn

Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

Immune responses and clinical outcomes in STAND, a randomized phase 2 study evaluating optimal sequencing of sipuleucel-T (sip-T) and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC) after local therapy failure.